2024-02-27T12:27:02Z
2024-02-27T12:27:02Z
2023-11-15
2024-02-27T12:27:02Z
Understanding the molecular mechanisms of lung function trajectories that progress to chronic obstructive pulmonary disease (COPD) (pre-COPD trajectories), especially those with a rapidly declining phenotype, should inform preventive interventions. The Tasmanian Longitudinal Health Study (TAHS) previously defined life-course lung function trajectories by serial spirometry in a cohort of all seven-year-old school children in the state of Tasmania recruited in 1968 and followed up to age 53 years (1). Of the six pre-bronchodilator FEV1 lifetime trajectories identified, three collectively accounted for 75% of chronic obstructive pulmonary disease (COPD) prevalence at age 53 years (2). These high-risk trajectories were: 1) early below average lung function (with usual rate of subsequent decline), 2) persistently low, and 3) early below average lung function with accelerated decline. The TAHS cohort provides a unique opportunity to investigate molecular factors associated with disadvantaged trajectories, and we conducted a pilot study in this cohort to characterize associations with COPD high-risk trajectories to inform more extensive longitudinal studies in the future.
Artículo
Versión aceptada
Inglés
Malalties del pulmó; Genètica; Epigènesi; Pulmonary diseases; Genetics; Epigenesis
American Thoracic Society
Versió postprint del document publicat a: https://doi.org/10.1164/rccm.202306-1025LE
American Journal of Respiratory and Critical Care Medicine, 2023, vol. 208, num.10, p. 1135-1137
https://doi.org/10.1164/rccm.202306-1025LE
(c) American Thoracic Society, 2023